Mallinckrodt will buy Maryland-based Sucampo Pharmaceuticals for about $840 million, the companies said, as the drug giant looks to diversify its portfolio after regulatory scrutiny has hurt its opioid sales. " News Highlights: Top Company News of the Day" via FOX BIZ http://ift.tt/2zynIZP
No comments:
Post a Comment